OMASP.HEOMASP.HEHEL
Loading
EBITDA Margin Over TimeContracting
Percentile Rank0
3Y CAGR-26.5%
5Y CAGR-12.8%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-26.5%/yr
vs +9.1%/yr prior
5Y CAGR
-12.8%/yr
Recent deceleration
Acceleration
-35.6pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
202518.87%-8.0%
202420.51%-47.8%
202339.32%-17.4%
202247.59%-22.3%
202161.29%+64.2%
202037.32%-3.4%
201938.65%+14.9%
201833.64%-18.2%
201741.12%+20.3%
201634.18%-